Watch this informative video where Dr. Jill Johnsen outlines the benefits of genotyping to enhance the treatment of von Willebrand disease (VWD), the increasing use of this diagnostic tool, obstacles to genotyping for VWD, and the type of data needed to improve treatment success.
The benefit of genotyping, or genetic testing to categorize the type of VWD that a patient has, is helping to ensure that health care providers select the best treatment for a particular patient. DNA-sequencing data helps improve the accuracy of diagnosis and is becoming more widespread in the treatment of VWD.
This content is not intended to be a substitute for professional medical or nursing advice, counseling, diagnosis or treatment. Please consult with your local Hemophilia Treatment Center physician or other health care provider if you have any questions related to management of bleeding disorders.
Este contenido no tiene como objetivo reemplazar el consejo, asesoramiento, diagnóstico o tratamiento de un médico o enfermero profesional. Consulte con el médico de su Centro de Tratamiento para la Hemofilia local u otro proveedor de atención médica si tiene preguntas relacionadas con el manejo de los trastornos hemorrágicos.